Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023

AML - 1359

Global, Regional, and National Macroeconomic Burden of Acute Myeloid Leukemia: A Value-of-Lost-Welfare Analysis of 184 Countries, 2023

Sai Varun Gadde

Poster Presenter: Sai Varun Gadde

Thumbnail for Second-Generation BTK Inhibitors vs Ibrutinib in CLL: A Systematic Review and Meta-Analysis of Efficacy and Safety

CLL - 1363

Second-Generation BTK Inhibitors vs Ibrutinib in CLL: A Systematic Review and Meta-Analysis of Efficacy and Safety

Chris Cooper

Poster Presenter: Chris Cooper

Thumbnail for Racial Disparities in Age at Leukemic Transformation and Temporal Progression Patterns in Myelodysplastic Syndromes: A SEER 18 Population-Based Analysis

Previous 1...109 110 111 112 113 114 115...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

MDS - 1364

Racial Disparities in Age at Leukemic Transformation and Temporal Progression Patterns in Myelodysplastic Syndromes: A SEER 18 Population-Based Analysis

Yagna Priya Chirrareddy

Poster Presenter: Yagna Priya Chirrareddy

Thumbnail for Reduced Mortality, Cytopenias, and Cardiovascular Events With Asciminib ComparedWith Ponatinib in Previously Treated Chronic Myeloid Leukemia: A Propensity-MatchedReal-World Analysis

CML - 1365

Reduced Mortality, Cytopenias, and Cardiovascular Events With Asciminib ComparedWith Ponatinib in Previously Treated Chronic Myeloid Leukemia: A Propensity-MatchedReal-World Analysis

Layal Sharrouf

Poster Presenter: Layal Sharrouf

Thumbnail for Front-Loaded Survival Benefit of RIC in DLBCL: Consistent Early Response Across Racial Groups in 95,531 Patients

ABCL - 1368

Front-Loaded Survival Benefit of RIC in DLBCL: Consistent Early Response Across Racial Groups in 95,531 Patients

Shivam Patel

Poster Presenter: Shivam Patel

Thumbnail for Real-World Renal Toxicity and Survival Outcomes Following Hematopoietic Stem Cell Transplantation: A Propensity Score-Matched TriNetX Database Analysis of Total Body Irradiation Versus Chemotherapy-Only Conditioning

CT - 1369

Real-World Renal Toxicity and Survival Outcomes Following Hematopoietic Stem Cell Transplantation: A Propensity Score-Matched TriNetX Database Analysis of Total Body Irradiation Versus Chemotherapy-Only Conditioning

Wei Ju Lin

Poster Presenter: Wei Ju Lin

$Thumbnail for Comparative Real-World Outcomes of CAR T-Cell Therapy vs Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Propensity-Matched TriNetX Analysis$

MM - 1370

Comparative Real-World Outcomes of CAR T-Cell Therapy vs Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Propensity-Matched TriNetX Analysis

Rukash Khan Niazi

Poster Presenter: Rukash Khan Niazi

Thumbnail for Changes in Thoracic Body Composition After Induction Chemotherapy and Outcomes in Patients With Acute Lymphoblastic Leukemia

ALL - 1372

Changes in Thoracic Body Composition After Induction Chemotherapy and Outcomes in Patients With Acute Lymphoblastic Leukemia

Frida Rodriguez-Contreras

Poster Presenter: Frida Rodriguez-Contreras

Thumbnail for Epigenetic Gene Expression Profiling as a Predictor of Ex Vivo Venetoclax Sensitivity in Acute Myeloid Leukemia

AML - 1373

Epigenetic Gene Expression Profiling as a Predictor of Ex Vivo Venetoclax Sensitivity in Acute Myeloid Leukemia

Pranav Singh

Poster Presenter: Pranav Singh

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors